These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 20386553

  • 1. The effects of phenol neurolysis of the obturator nerve on the distribution of buttock-seat interface pressure in spinal cord injury patients with hip adductor spasticity.
    Yaşar E, Tok F, Taşkaynatan MA, Yilmaz B, Balaban B, Alaca R.
    Spinal Cord; 2010 Nov; 48(11):828-31. PubMed ID: 20386553
    [Abstract] [Full Text] [Related]

  • 2. Neurolytic phenol blockade of the obturator nerve for severe adductor spasticity.
    Akkaya T, Unlu E, Alptekin A, Gumus HI, Umay E, Cakci A.
    Acta Anaesthesiol Scand; 2010 Jan; 54(1):79-85. PubMed ID: 19839948
    [Abstract] [Full Text] [Related]

  • 3. Ultrasound and electrical stimulator-guided obturator nerve block with phenol in the treatment of hip adductor spasticity in long-term care patients: a randomized, triple blind, placebo controlled study.
    Lam K, Wong D, Tam CK, Wah SH, Myint MW, Yu TK, So KK, Cheung G, Au KM, Fu MH, Wu YM, Kng CP.
    J Am Med Dir Assoc; 2015 Mar; 16(3):238-46. PubMed ID: 25458446
    [Abstract] [Full Text] [Related]

  • 4. Neurolytic blockade of the obturator nerve for intractable spasticity of adductor thigh muscles.
    Viel EJ, Perennou D, Ripart J, Pélissier J, Eledjam JJ.
    Eur J Pain; 2002 Mar; 6(2):97-104. PubMed ID: 11900470
    [Abstract] [Full Text] [Related]

  • 5. Ultrasonographically guided obturator nerve block for bilateral adductor spasticity in a paraplegic patient.
    Yalcin E, Akyuz M, Ilgu O, Ozer NB.
    Spinal Cord; 2014 Aug; 52 Suppl 2():S24-6. PubMed ID: 25082379
    [Abstract] [Full Text] [Related]

  • 6. Temporospatial parameters of gait after obturator neurolysis in patients with spasticity.
    Ofluoglu D, Esquenazi A, Hirai B.
    Am J Phys Med Rehabil; 2003 Nov; 82(11):832-6. PubMed ID: 14566149
    [Abstract] [Full Text] [Related]

  • 7. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J, Entner T.
    Wien Klin Wochenschr; 2001 Nov; 113 Suppl 4():20-4. PubMed ID: 15506048
    [Abstract] [Full Text] [Related]

  • 8. Selective blocking of the anterior branch of the obturator nerve in children with cerebral palsy.
    Kwon JY, Kim JS.
    Am J Phys Med Rehabil; 2009 Jan; 88(1):7-13. PubMed ID: 17993980
    [Abstract] [Full Text] [Related]

  • 9. Practice patterns for spasticity management with phenol neurolysis.
    Karri J, Mas MF, Francisco GE, Li S.
    J Rehabil Med; 2017 Jun 28; 49(6):482-488. PubMed ID: 28537343
    [Abstract] [Full Text] [Related]

  • 10. Attenuation of facial muscle spasticity with intramuscular phenol neurolysis.
    Greenbaum MG, Young MA, Frank JM.
    Arch Phys Med Rehabil; 1993 Feb 28; 74(2):217-9. PubMed ID: 8431109
    [Abstract] [Full Text] [Related]

  • 11. [Clinical research of electroacupuncture combined with acupoint-injection of botulinum toxin A in treating the muscle spasticity by spinal cord injury].
    Xing ST, Wang D, Wen XH, Wu ZQ, Sun Q, Zhang DW, Cheng Y, Yan D, Yu F.
    Zhongguo Gu Shang; 2010 May 28; 23(5):350-3. PubMed ID: 20575288
    [Abstract] [Full Text] [Related]

  • 12. The treatment of spasticity with Delta9-tetrahydrocannabinol in persons with spinal cord injury.
    Hagenbach U, Luz S, Ghafoor N, Berger JM, Grotenhermen F, Brenneisen R, Mäder M.
    Spinal Cord; 2007 Aug 28; 45(8):551-62. PubMed ID: 17043680
    [Abstract] [Full Text] [Related]

  • 13. A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on spasticity in persons with spinal cord injury.
    Pooyania S, Ethans K, Szturm T, Casey A, Perry D.
    Arch Phys Med Rehabil; 2010 May 28; 91(5):703-7. PubMed ID: 20434606
    [Abstract] [Full Text] [Related]

  • 14. Electrical stimulation in treating spasticity resulting from spinal cord injury.
    Bajd T, Gregoric M, Vodovnik L, Benko H.
    Arch Phys Med Rehabil; 1985 Aug 28; 66(8):515-7. PubMed ID: 3875331
    [Abstract] [Full Text] [Related]

  • 15. Phenol neurolysis in people with spinal cord injury: a descriptive study.
    Korupolu R, Malik A, Pemberton E, Stampas A, Li S.
    Spinal Cord Ser Cases; 2022 Dec 09; 8(1):90. PubMed ID: 36481543
    [Abstract] [Full Text] [Related]

  • 16. Interadductor approach to obturator nerve blockade for spastic conditions of adductor thigh muscles.
    Wassef MR.
    Reg Anesth; 1993 Dec 09; 18(1):13-7. PubMed ID: 8448092
    [Abstract] [Full Text] [Related]

  • 17. The short-term effect of hippotherapy on spasticity in patients with spinal cord injury.
    Lechner HE, Feldhaus S, Gudmundsen L, Hegemann D, Michel D, Zäch GA, Knecht H.
    Spinal Cord; 2003 Sep 09; 41(9):502-5. PubMed ID: 12934090
    [Abstract] [Full Text] [Related]

  • 18. Clonidine transdermal system for treatment of spasticity in spinal cord injury.
    Weingarden SI, Belen JG.
    Arch Phys Med Rehabil; 1992 Sep 09; 73(9):876-7. PubMed ID: 1514897
    [Abstract] [Full Text] [Related]

  • 19. Functional outcome after delivery of intrathecal baclofen.
    Parke B, Penn RD, Savoy SM, Corcos D.
    Arch Phys Med Rehabil; 1989 Jan 09; 70(1):30-2. PubMed ID: 2916915
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of tizanidine in the treatment of spasticity in patients with spinal cord injury. North American Tizanidine Study Group.
    Nance PW, Bugaresti J, Shellenberger K, Sheremata W, Martinez-Arizala A.
    Neurology; 1994 Nov 09; 44(11 Suppl 9):S44-51; discussion S51-2. PubMed ID: 7970010
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.